The latest Investing Matters Podcast episode with multi-award-winning fund manager and international bestselling author Lee Freeman-Shor has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Im more looking at the FD TBH, Jon is being judged too early IMO (but the warning signs are there ) to use the Football link again -your only as good as you last result - everyone was up his ~rse when the SP 4 folded 😂
He is as bad as it gets, but....
Sometimes the product and the science finds a way regardless
Well done Burrows for causing such division among investors. Great way to run a company.
I haven't posted I'm avdfn for those reasons, it's not for me I'd cope 5 mins and remove myself.
I think we can achieve a good deal here with a respectful mindset, my mind has been stretched a great deal on lse lately so its reflected on my posts here.
I'll come back fresher, I do see positive feedback, but it's hard to be blind to the shortcomings so far.
We was lied to and that still weighs heavily, but I see buys so I'll have a bit more confidence once I take time to go over the latest reports with more emphasis
Thanks.
Look if you guys want to go off line via whatsapp or telegram then try it by all means.
It has worked for me in the past and still does. Made some friends for life that way when we had time to exchange etc without the heat of being a PBB.
I do not expect to be invited nor would I as I have other groups I am in away from LSE which at times is rubbish anyway. Not as bad as ADVFN which will for dedicated trolls only these days and has zero moderation to control them and I haven't posted on advfn for a very long time and have zero intention of doing so again. It's good for charts and prices and RNS updates but that's it.
LSE is in general becoming a rampers r us site which is positive at least but one needs to know your posters pretty well.
Good Luck with your private group and hope it works well for you.
New uncle, you do offer great points
Give me sunshine, i like your level of knowledge I'll be happy to spectate your conversations with eagerness from now on
Sorry guys,
Hold my hands up I can't handle these boards much these days.
I have 4 boards I visit, everyone is just argument about who is right or wrong.
Some complete chaos I don't even know where to interject.
The whole burrows issue is evident but a tiring one now.
Just seeing investment after investment become a dog fight, I try to stay positive but it's taking its toll.
GLA
Not about being told im wrong - its the "What about this, what about that 1 test a day etcetc" they clearly have read or listened to anything put out by the company - so whats the point ? you just get another moronic onliner
NU Agree with you there..
PSE and CIRT are different Beasts IMO, same process to follow, but diferent end of the spectrum in many ways.
PSE is at urology step 2 diagnotic level - currently one above GP in the pecking orders
Cirt is at potentailly end of life care - at a very high level.
but like everything medical - there are processes and standard of care to penetrate, and the company needs to have a way of deriving that change whilst generating revune. Its not about Steve running about with a suitcase of tests - They have stated the plan, what they intend to do , and if the update is belived they have put quite a few big ticks against some of those barriers.
I think the people they have onboard are impressive, ignoring anything rampy - getting the 1st Cirt at a hospital network level is a big obstacle.. IF the 3 follow as within the update then it show CiRT is now being taken seriously .. CIRRP is fantastic oppertunity - if they get it, that will drop within 3-4 weeks. and even on a cost plus basis will be great news.
But for me the revune focus must now sit with PSE
Barriers are must less, its only just getting going and will be outstripping Cirt in sales numbers, the conceirge groups , london clinic, good body etc, are the first, so we are looking for more of the same.
Revenue will continue to lag, but PSE will be paid quicker and easier IMO - its not about getting 1000 test a dat before yearend, that never been stated, we just need to see evidence that the plan put in place at the end/start of the year are working - Alittle to early for that, and the next 3 months will be important
Givmesunshine.
A WhatsApp group would be a great step forward in my opinion as I have stopped contributing to this board due to circumstances that I would not post on here.
GLA LTHS
Thanks for that,
Only reason I'm not I'm the best of moods is because you left, when you was consistently told your wrong.
But hey ho
If anything OBD actually got ahead of themselves in many aspects.
I just wish that the CEO had been a bit less rampy in his assessment of test volumes etc etc which all came back to bite him and his shareholders just when OBD was primed to move into some decent valuation areas. To then avoid the inevitable placing for so long just made a bad situation much worse for shareholders. That sits with BoD 100% and is why the SP is trading near all time lows. Done
Moving on, now it's all about the run rate for tests and hopefully at some point in the near future validation (whatever form that comes in). It might not be the holy grail of NICE but perhaps there are other ways and as the CEO says maybe more emphasis on CIRT could deliver sooner than PSE.
Is the company distracted by PSE now or can they effectively run two horses in the testing race just as well as one?
I would think CIRT should be the problem child they can turn into a cash cow and then perhaps a rising star sooner rather than later? Boston Matrix
Hi both
TBF I think NU put over a reasonable negative view, However LSE and ADVFN (which is awful) have become full of idiots who shout from terraces "You dont know what your doing !!", "The Burrows is a w#nk##" etc etc :) and dont have any desire to go above that level and it get very boring
There are were some very interesting updates - and a clear plan IMO, whether it works is another thing, but they have been consistent on the strategy- CIRT has been tricky - Yes, but that doesnt make them incomptent, and they have long stated to order of play and steps. Some key ones have just started to mobilise .. and im suprised that they barely get mentioned above the crsp on here.
CIRRP no one care's? insignicant ?
CIRT now getting invloved Health care network level (a long stated plan)
PSE
That said Jon does Irk me somewhat - Some of the things he says come across very cringy to me, (Turing away health networks because they dont use enough Cirt test made me choke on my coffee:) . Which may be true, but its just the way he says it. but we do have to remember in Bio timescales under ihs leadership they have done a hell of alot very quickly and i do think he knows exactly what needs doing myself .
May be worth setting u a whats App group
No it isn't
OK
Well you.and your buddy got eid of givemesunshine for remaining positive.
Now this is my last.
Ta ta
Omg you are paranoid I haven't posted a single negative today.
Get a grip
No, our conversation is about the subject tho.
Or am I under a more positive heading feed?
When someone posts a positive here, your here to challenge it.
And everyone else to bring up burrows.
So no one really wants to post positive, as your hear, miserys uncle
Did I mention burrows today?
No, I just feel you are angry.
I'm feeling nothing really, it's just an investment.
Just tired of burrows deriven posts taking up.any debate or positive outlook.
Change the narrative
Change the mood
Feeling sorry for me?, I'm good honestly. Its just an investment, happy to let it run.
Go on resist replying if you can
Dusty,
I actually feel sorry for you.
Every time you post you want to draw an angry reply by attacking others.
Good Luck with that strategy
I know what I do know, you just like arguing.
No one has had adequate time to have these conversations in full, as we are drained by constant interruptions of burrows is this, well burrows done that.
Anyone remotely tries being positive, has had 3 messages avout burrows to contend with, no matter what a poster says, it comes round to that.
So ye, where left with glasshouse negativity and you seem to be the spokesperson for it.
Then have the audacity to then tell me to go fetch you something you can provide for yourself.
Mate your starting to do my head in.
I'll keep this a more silent investment now
Funny how I managed to find the company strategy in seconds of searching......wonder why others didn't share as they must know themselves already?
Validation,Validation,Validation???
Rejuvenating CiRT demand: OBD’s strategy to raise awareness and rejuvenate sales of the CiRT test appear to have been successful. Leading indicators and subsequent demand from early adopting physicians have been highly encouraging. While revenues remain modest for now, ongoing progress is evident largely thanks to efforts to improve awareness as well as the availability in the US of a unique CPT PLA code facilitating reimbursement. Of particular note in the release today are ongoing efforts to better co-ordinate the use of CiRT by physicians through forging relationships with regional healthcare systems in the US. This has resulted in the first of potentially seven healthcare systems being onboarded as part of a prospective observational registry study. This should result in greater awareness and more widespread use of CiRT amongst physicians with leading indicators suggesting that this is already occurring. We look forward to the company providing an update on this development in due course (shortly after September 30th). Ultimately this initiative should help facilitate data in support of CiRT inclusion in the National Comprehensive Cancer Guidelines (NCCN) which we believe would significantly increase awareness amongst clinicians and encourage adoption. In the UK, we would highlight the efforts by BUPA to actively encourage use of CiRT amongst its network of healthcare providers. Also, we also look forward to new leadership in the CiRT sales team in the US continuing the positive impact of the clinical advisory boards while recognising that the small size of the sales team likely underplays the potential of the CiRT test for now.
Buying because the shares are cheap, they see the possibility of positive movement north of here, can perhaps bring there average to meet in the middle and then reduce there risk 😉